BAJAJ BROKING

Notification
No new Notification messages
Wagons Learning IPO is Open!
Apply for the Wagons Learning IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

523620

PHRMASI

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

PHAARMASIA LTD. Share Price Update

As of the latest trading session, PHAARMASIA LTD. share price is currently at ₹ 30.2, which is down by ₹ -0.59 from its previous closing. Today, the stock has fluctuated between ₹ 30.20 and ₹ 31.40. Over the past year, PHAARMASIA LTD. has achieved a return of -27.05 %. In the last month alone, the return has been 3.03 %. Read More...

PHAARMASIA LTD. fundamentals


  • Market cap (Cr)

  • P/E Ratio (TTM)

  • Beta

  • Book Value / share

  • Return on equity

    %

  • EPS (TTM)

  • Dividend yield

    %

  • Net profit/quarter (Cr)

info icon alternate text
  • Market cap (Cr)

    20.60

  • P/E Ratio (TTM)

    -34.71

  • Beta

    0.45

  • Book Value / share

    8.33

  • Return on equity

    0.00%

  • EPS (TTM)

    0.00

  • Dividend yield

    %

  • Net profit/quarter (Cr)

    -0.70

info icon alternate text

PHAARMASIA LTD. Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2024 (Values in Cr)
Revenue 4.72
Operating Expense 5.60
Net Profit -0.70
Net Profit Margin (%) -14.83
Earnings Per Share (EPS) -1.02
EBITDA -0.60
Effective Tax Rate (%) -1.44
Particulars SEP 2024 (Values in Cr)
Revenue 5.93
Operating Expense 6.79
Net Profit -0.64
Net Profit Margin (%) -10.79
Earnings Per Share (EPS) -0.94
EBITDA -0.57
Effective Tax Rate (%) 0.00
Particulars JUN 2024 (Values in Cr)
Revenue 8.29
Operating Expense 8.19
Net Profit 0.28
Net Profit Margin (%) 3.37
Earnings Per Share (EPS) 0.40
EBITDA 0.33
Effective Tax Rate (%) -12.00
Particulars MAR 2024 (Values in Cr)
Revenue 9.99
Operating Expense 9.74
Net Profit 0.47
Net Profit Margin (%) 4.70
Earnings Per Share (EPS) 0.69
EBITDA 0.53
Effective Tax Rate (%) -9.09
Particulars DEC 2023 (Values in Cr)
Revenue 5.08
Operating Expense 5.75
Net Profit -0.56
Net Profit Margin (%) -11.02
Earnings Per Share (EPS) -0.83
EBITDA -0.44
Effective Tax Rate (%) -3.70
Particulars MAR 2024 (Values in Cr)
Revenue 30.59
Operating Expense 31.80
Net Profit -0.52
Net Profit Margin (%) -1.69
Earnings Per Share (EPS) -0.76
EBITDA -0.16
Effective Tax Rate (%) 5.45
Particulars MAR 2023 (Values in Cr)
Revenue 27.49
Operating Expense 29.43
Net Profit -1.26
Net Profit Margin (%) -4.58
Earnings Per Share (EPS) -1.84
EBITDA -1.02
Effective Tax Rate (%) 11.88
Particulars MAR 2022 (Values in Cr)
Revenue 17.22
Operating Expense 19.24
Net Profit -1.55
Net Profit Margin (%) -9.00
Earnings Per Share (EPS) -2.27
EBITDA -1.27
Effective Tax Rate (%) 1.28
Particulars MAR 2021 (Values in Cr)
Revenue 19.90
Operating Expense 20.31
Net Profit 0.31
Net Profit Margin (%) 1.55
Earnings Per Share (EPS) 0.46
EBITDA 0.83
Effective Tax Rate (%) 35.41
Particulars MAR 2020 (Values in Cr)
Revenue 24.45
Operating Expense 24.07
Net Profit 0.54
Net Profit Margin (%) 2.20
Earnings Per Share (EPS) 0.79
EBITDA 1.40
Effective Tax Rate (%) 43.75
Particulars MAR 2024 (Values in Cr)
Book Value / Share 8.87
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.03
EBITDA Margin -0.52
Particulars MAR 2023 (Values in Cr)
Book Value / Share 9.62
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.02
EBITDA Margin -3.75
Particulars MAR 2022 (Values in Cr)
Book Value / Share 11.45
ROE % -17.98
ROCE % -17.75
Total Debt to Total Equity 0.00
EBITDA Margin -7.38
Particulars MAR 2021 (Values in Cr)
Book Value / Share 13.79
ROE % 3.34
ROCE % 5.02
Total Debt to Total Equity 0.01
EBITDA Margin 5.10
Particulars MAR 2020 (Values in Cr)
Book Value / Share 13.43
ROE % 6.08
ROCE % 10.43
Total Debt to Total Equity 0.02
EBITDA Margin 7.02
Particulars MAR 2024 (Values in Cr)
Net Income -0.54
Cash from Operations 0.10
Cash from Investing 0.00
Cash from Financing -0.16
Net change in Cash -0.05
Free Cash Flow 0.13
Particulars MAR 2023 (Values in Cr)
Net Income -1.43
Cash from Operations 0.64
Cash from Investing -0.01
Cash from Financing -0.16
Net change in Cash 0.47
Free Cash Flow 0.67
Particulars MAR 2022 (Values in Cr)
Net Income -1.56
Cash from Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00
Net change in Cash -0.16
Free Cash Flow 0.00
Particulars MAR 2021 (Values in Cr)
Net Income 0.47
Cash from Operations 0.49
Cash from Investing 0.00
Cash from Financing -0.02
Net change in Cash 0.22
Free Cash Flow 0.49
Particulars MAR 2020 (Values in Cr)
Net Income 0.96
Cash from Operations 0.33
Cash from Investing 0.00
Cash from Financing -0.11
Net change in Cash -0.03
Free Cash Flow 0.33
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 36.46 19.60 1.99 279.41 34.11 / 77.70
BLISS GVS PHARMA LTD 119.00 15.60 1.24 1253.91 92.25 / 184.95
CIPLA LTD 1549.65 25.08 4.41 125155.99 1310.05 / 1702.00
FERMENTA BIOTECH LIMITED 260.70 21.60 2.64 767.27 145.00 / 449.00
GLAXOSMITHKLINE PHARMA LT 2959.45 58.70 29.97 50134.87 1924.30 / 3147.45
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 36.46 21.96 6.19 279.41 34.11 / 77.70
AMRUTAJAN HEALTH LTD 692.80 40.61 6.72 2002.93 548.05 / 861.40
ASTRAZENECA PHARMA IND LT 8665.50 129.24 31.88 21663.75 5000.00 / 9199.00
BLISS GVS PHARMA LTD 119.00 15.45 1.22 1253.91 92.25 / 184.95

PHAARMASIA LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
30.20 -1.94 redarrow
red-green-graph indicator
8 Bearish
8 Bullish
  • 5 Days 30.40
  • 26 Days 30.20
  • 10 Days 29.90
  • 50 Days 32.80
  • 12 Days 29.80
  • 100 Days 37.50
  • 20 Days 29.80
  • 200 Days 40.60
30.80 PIVOT

First Support

30.80

First Resistance

30.80

Second Support

30.80

Second Resistance

30.80

Third Support

30.80

Third Resistance

30.80

RSI

49.58

ADX

25.82

MACD

-0.43

Williams % R

-39.97

Commodity Channel Index (CCI)

79.40

Date

2025-04-30

Week

434.00

Same Day

89.00

Month

212.00

1 Year

0.45

3 Year

0.23

Over 1 Month

3.03%

down

Over 1 Year

-27.05%

down

Over 3 Months

-33.77%

down

Over 3 Years

2.73%

down

Over 6 Months

-35.74%

down

Over 5 Years

15.72%

down

Invest with Confidence

Left Arrow
MTF boost
Buy Now. Pay Later

Boost your capital upto 5 X

img
IPO boost
Invest in IPOs
They give good returns
img
Right Arrow

PHAARMASIA LTD. shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
26.42%
Promoter Holdings
73.51%
FII
0.0%
DII
0.05%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Maneesh Pharmaceuticals Limited 3018732.0 (44.22%) Shareholding of Promoter and Promoter Group
Svizera Labs Pvt Ltd 2000000.0 (29.3%) Shareholding of Promoter and Promoter Group
Madhavi Pradeep Save 118054.0 (1.73%) Public Shareholding
Amruta Nishant Kalsekar 101512.0 (1.49%) Public Shareholding

News

Left Arrow
Right Arrow

PHAARMASIA LTD. corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

PHAARMASIA LTD. Share Price

Incorporated in 1981, Phaarmasia Limited (unit-I) is the part of the Maneesh Pharmaceutical Limited, with its headquarters and marketing office in Mumbai. M/s Phaarmasia Limited Unit-II was established in 1993-94. The Company is engaged in manufacturing and marketing of Oral contraceptive tablets' with various therapeutic dosage combinations along with iron tablets for Ministry of Health & Family Welfare and for Exports.

The plant is situated in a hygienic environment; free from dust, smoke, chemical & biological emission. Phaarmasia Ltd. Is an independent State-of-the-art-manufacturing unit having manufacturing facility of international standards with manufacturing capacity of more than 30 million units per annum.

During the year 2000, the company became a Sick Industrial Company under SICA and therefore the same was referred to the BIFR.

During past a few decades, Phaarmasia mastered and manufactured wide range of Pharmaceutical Formulations at a WHO-GMP
certified and ISO 9001-certified manufacturing facility.

Parent organization Indian Private
NSE symbol [-]
Founded 1981
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Share Price of Phaarmasia Ltd?

Answer Field

The share price of Phaarmasia Ltd for NSE is ₹ 0.00 and for BSE is ₹ 30.20.

What is the Market Cap of Phaarmasia Ltd?

Answer Field

The market cap of Phaarmasia Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 20.60 Cr. as of now.

What is the 52 Week High and Low of Phaarmasia Ltd?

Answer Field

The 52 Week High and Low of Phaarmasia Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 64.75 and ₹ 23.60.

How to Buy Phaarmasia Ltd share?

Answer Field

You can trade in Phaarmasia Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Phaarmasia Ltd?

Answer Field

The 1 year returns on the stock has been -27.05%.

What is the Current Share Price of Phaarmasia Ltd?

Answer Field

Phaarmasia Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 30.20 as on Apr 30 2025 03:15 PM.

What is the Market Cap of Phaarmasia Ltd Share?

Answer Field

The market cap of Phaarmasia Ltd for NSE ₹ 0.0 & for BSE ₹ 20.60 as on Apr 30 2025 03:15 PM.

What is the P/E Ratio of Phaarmasia Ltd Share?

Answer Field

As on Apr 30 2025 03:15 PM the price-to-earnings (PE) ratio for Phaarmasia Ltd share is -34.71.

What is the PB ratio of Phaarmasia Ltd Share?

Answer Field

As on Apr 30 2025 03:15 PM, the price-to-book (PB) ratio for Phaarmasia Ltd share is 8.33.

How to Buy Phaarmasia Ltd Share?

Answer Field

You can trade in Phaarmasia Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Phaarmasia Ltd Share on Bajaj Broking App?

Answer Field

To buy Phaarmasia Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Phaarmasia Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|